Epitalon

Research-Grade

Epitalon is a synthetic tetrapeptide designed by Russian gerontologist Vladimir Khavinson based on work with the pineal-gland extract Epithalamin. A long-running line of Eastern European research has examined Epitalon in rodent and human cohort studies, reporting effects on telomerase expression, melatonin restoration, circadian rhythm, and all-cause mortality in multi-year institutional cohorts. Most of this evidence exists outside mainstream Western peer-review channels and interpretation remains contested. Epitalon is typically administered as short subcutaneous courses (10 days) repeated 2–3 times per year in published Russian protocols. It is classified as a research peptide globally and is widely used off-label in longevity practice despite the contested evidence base.